Research Directory

Europe's pharma groups change product mix

Read more

Novartis sets out its vision for pharma R&D

Read more

Battle looms over immunotherapy combination

Read more

Innate Pharma aims to regain leadership in IO

Read more

Takeovers refocus Sanofi on rare diseases

Read more

The case for optimism for Europe's biotech sector

Read more

Priorities of the new Novartis CEO

Read more

Ipsen aspires to role as speciality oncology player

Read more

Drugs for orphan diseases are no longer rare

Read more

JP Morgan forum ends on a positive note

Read more